Bitget Launches “Gold Fast or Go Home Challenge” for Gold CFD Trading VICTORIA, Seychelles, May 20, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), has launched the “Gold Fast or Go Home Challenge,” a global campaign built around faster access to gold CFD trading on the Bitget app. The campaign follows Bitget’s […]
Month: May 2026
Bitget Brings Institutional-Grade Stablecoin Yield to All Users with USDGO, Offering Up to 4.3% APR
Bitget Brings Institutional-Grade Stablecoin Yield to All Users with USDGO, Offering Up to 4.3% APR VICTORIA, Seychelles, May 20, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), has launched USDGO, GO Uncapped, a passive earning initiative that allows users to earn up to 4.3% APR simply by holding USDGO in their spot […]
Meltwater Wins 2026 PRWeek Global Award for “Best PR Software or AI Platform”
The award recognizes Meltwater’s AI-powered innovations that provide actionable intelligence for PR, Communications and Marketing teams SAN FRANCISCO, May 20, 2026 (GLOBE NEWSWIRE) — Meltwater, the global leader in actionable intelligence for PR, Communications and Marketing teams, has been awarded the PRWeek Global Award for Best PR Software or AI Platform, recognizing the company’s leadership in building solutions that turn […]
Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain
ALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its two aseptic suites in Valladolid, Spain. The $4 million dollar investment is in accordance with the EU’s GMP Annex 1 standards. The central feature of the […]
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients with Alzheimer’s disease. The Phase 2 […]